GlassScriptPhysician profile
Hetal Patel
NPI 1811535537
$1,291.27
in general payments reported to CMS, 2019-2025
16 companies · $457 in 2025
The $457 reported for 2025 was more than what 91% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.48 · 2022: $334 · 2023: $293 · 2024: $137 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $886.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $247.75 | 2022-2025 | Qelbree, Qelbree |
| Corium, LLC | $214.51 | 2022-2024 | Azstarys |
| Lnhc, INC | $143.99 | 2025 | Zelsuvmi |
| Allergan, INC. | $131.48 | 2022 | |
| Sanofi Pasteur INC. | $108.08 | 2021-2024 | |
| Seqirus USA INC | $70.63 | 2025 | Flucelvax |
| Glaxosmithkline, LLC. | $68.91 | 2021-2025 | Bexsero |
| Collegium Pharmaceutical, INC. | $67.09 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $46.81 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $45.28 | 2023 | Flumist Quadrivalent |
| Dexcom, INC. | $39.36 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $35.79 | 2025 | Rotateq, Vaxelis, Gardasil 9 |
| Phadia US INC. | $19.70 | 2022 | |
| Ironshore Pharmaceuticals INC. | $18.30 | 2024 | |
| Pfizer INC. | $18.23 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $15.36 | 2023 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hetal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.